{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:10:58Z","timestamp":1762161058317},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"vor","delay-in-days":615,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jval.2013.10.005","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T06:18:53Z","timestamp":1389766733000},"page":"116-130","source":"Crossref","is-referenced-by-count":28,"title":["Valuing the Health States Associated with Chlamydia trachomatis Infections and Their Sequelae: A Systematic Review of Economic Evaluations and Primary Studies"],"prefix":"10.1016","volume":"17","author":[{"given":"Louise J.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Auguste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2013.10.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16320","article-title":"Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome)","volume":"16","author":"Brazier","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2013.10.005_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.healthpol.2012.09.012","article-title":"Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions","volume":"108","author":"Nicod","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.jval.2013.10.005_bib3","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jval.2013.10.005_bib4","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2007"},{"key":"10.1016\/j.jval.2013.10.005_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00019053-200826090-00007","article-title":"Valuing health states for use in cost-effectiveness analysis","volume":"26","author":"Brazier","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2013.10.005_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jval.2012.05.003","article-title":"Using health state utility values in models exploring the cost-effectiveness of health technologies","volume":"15","author":"Ara","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.10.005_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005650-200006000-00004","article-title":"One thousand health-related quality-of-life estimates","volume":"38","author":"Tengs","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2013.10.005_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/11591570-000000000-00000","article-title":"Challenges in health state valuation in paediatric economic evaluation","volume":"29","author":"Ungar","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2013.10.005_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/gps.2090","article-title":"What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia","volume":"24","author":"Banerjee","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jval.2013.10.005_bib10","series-title":"Methods for the Economic Evaluation of Health Care Programs","author":"Drummond","year":"2005"},{"key":"10.1016\/j.jval.2013.10.005_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.10.005_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0272989X12454941","article-title":"Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2","volume":"32","author":"Roberts","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.10.005_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.10.005_bib14","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.jval.2013.10.005_bib15","unstructured":"National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. 2013. Available from: http:\/\/www.nice.org.uk\/media\/D45\/1E\/GuideToMethodsTechnologyAppraisal2013.pdf. [Accessed May 10, 2013]."},{"key":"10.1016\/j.jval.2013.10.005_bib16","unstructured":"National Institute for Health and Care Excellence. Methods for the Development of NICE Public Health Guidance (3rd ed.). Available from: http:\/\/publications.nice.org.uk\/methods-for-the-development-of-nice-public-health-guidance-third-edition-pmg4. [Accessed September 24, 2013]."},{"key":"10.1016\/j.jval.2013.10.005_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/sti.2005.017517","article-title":"Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling","volume":"82","author":"Roberts","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/sti.78.6.406","article-title":"Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies","volume":"78","author":"Honey","year":"2002","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib19","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/OLQ.0b013e3181723dba","article-title":"The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature","volume":"35","author":"Gift","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib20","unstructured":"World Health Organization. Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections 2008. Available from: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/stisestimates\/en\/index.html. [Accessed May 10, 2013]."},{"key":"10.1016\/j.jval.2013.10.005_bib21","unstructured":"Public Health England Health Protection Report. Sexually transmitted infections and chlamydia screening in England, 2012. 2013. Available from: http:\/\/www.hpa.org.uk\/hpr\/infections\/hiv_sti.htm#stis. [Accessed June 8, 2013]."},{"key":"10.1016\/j.jval.2013.10.005_bib22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(01)06886-6","article-title":"Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection","volume":"358","author":"Fenton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2013.10.005_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/OLQ.0b013e31823e2ff7","article-title":"Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999\u20132008","volume":"39","author":"Datta","year":"2012","journal-title":"Sex Transm"},{"key":"10.1016\/j.jval.2013.10.005_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2458-11-230","article-title":"Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: feasibility and prevalence","volume":"11","author":"Bozicevic","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2013.10.005_bib25","series-title":"Sexually Transmitted Diseases","first-page":"575","article-title":"Chlamydia trachomatis infections in the adult","author":"Stamm","year":"2008"},{"key":"10.1016\/j.jval.2013.10.005_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.epidem.2010.04.002","article-title":"Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes","volume":"2","author":"Althaus","year":"2010","journal-title":"Epidemics"},{"key":"10.1016\/j.jval.2013.10.005_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-12-187","article-title":"Timing of progression of Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study","volume":"12","author":"Herzog","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib28","doi-asserted-by":"crossref","first-page":"c1642","DOI":"10.1136\/bmj.c1642","article-title":"Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial","volume":"340","author":"Oakeshott","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2013.10.005_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/aje\/kws583","article-title":"Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model","volume":"178","author":"Price","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"Suppl.","key":"10.1016\/j.jval.2013.10.005_bib30","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/652392","article-title":"Introduction: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control","volume":"201","author":"Gottlieb","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib31","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/QCO.0b013e3282f3e6a5","article-title":"Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes","volume":"21","author":"Baud","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.jval.2013.10.005_bib33","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1093\/cid\/cir699","article-title":"Chlamydial and gonococcal infections in infants and children","volume":"53","author":"Hammerschlag","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib34","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00404-012-2240-7","article-title":"Female genital Chlamydia trachomatis infection: where are we heading?","volume":"285","author":"Mylonas","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jval.2013.10.005_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/fampra\/cml031","article-title":"Population screening for Chlamydia trachomatis infection in the UK: a qualitative study of the experiences of those screened","volume":"23","author":"Mills","year":"2006","journal-title":"Fam Pract"},{"key":"10.1016\/j.jval.2013.10.005_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/sti.79.5.372","article-title":"Sex differences in the experience of testing positive for genital chlamydia infection: a qualitative study with implications for public health and for a national screening programme","volume":"79","author":"Darroch","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/OLQ.0b013e31827bd637","article-title":"Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials","volume":"40","author":"Gottlieb","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/OLQ.0b013e31825159ff","article-title":"Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies","volume":"39","author":"Herzog","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jncimonographs\/lgi010","article-title":"Motivation for parenthood after cancer: a review","volume":"34","author":"Schover","year":"2005","journal-title":"J Natl\u00a0Cancer\u00a0Inst Monogr"},{"issue":"Suppl.","key":"10.1016\/j.jval.2013.10.005_bib40","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.ygyno.2005.07.106","article-title":"Cancer-related infertility","volume":"99","author":"Carter","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jval.2013.10.005_bib41","first-page":"1","article-title":"Health-related quality of life in women with endometriosis: a systematic review","volume":"5","author":"Jia","year":"2012","journal-title":"J Ovar Res"},{"key":"10.1016\/j.jval.2013.10.005_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westrom","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e3181557c25","article-title":"Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: The PID Evaluation and Clinical Health (PEACH) study","volume":"35","author":"Ness","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11317060-000000000-00000","article-title":"Methods for measuring temporary health states for cost-utility analyses","volume":"27","author":"Wright","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2013.10.005_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1257\/jel.40.2.351","article-title":"Time discounting and time preference: a critical review","volume":"40","author":"Frederick","year":"2002","journal-title":"J Econ Lit"},{"key":"10.1016\/j.jval.2013.10.005_bib46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1524-4733.2010.00773.x","article-title":"The value of correcting values: influence and importance of correcting TTO scores for time preference","volume":"13","author":"Attema","year":"2010","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.10.005_bib47","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0272989X9901900416","article-title":"Whose preferences count?","volume":"19","author":"Dolan","year":"1999","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.10.005_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1744133107004355","article-title":"Developing methods that really do value the Q in the QALY","volume":"3","author":"Dolan","year":"2008","journal-title":"Health Econ Policy Law"},{"issue":"4","key":"10.1016\/j.jval.2013.10.005_bib49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2013.10.005_bib50","unstructured":"Centre for Reviews and Dissemination, University of York. Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care. York: Centre for Reviews and Dissemination, University of York, 2009. Available from: http:\/\/www.york.ac.uk\/inst\/crd\/pdf\/Systematic_Reviews.pdf. [Accessed November 22, 2012]."},{"key":"10.1016\/j.jval.2013.10.005_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1471-0528.2002.00223.x","article-title":"Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness","volume":"109","author":"Roberts","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jval.2013.10.005_bib52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1524-4733.2007.00189.x","article-title":"Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals","volume":"10","author":"Smith","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.10.005_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/sti.2009.036673","article-title":"Sex workers can be screened too often: a cost-effectiveness analysis in Victoria, Australia","volume":"86","author":"Wilson","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"Suppl.","key":"10.1016\/j.jval.2013.10.005_bib54","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/OLQ.0b013e31818b64ac","article-title":"The program cost and cost-effectiveness of screening men for chlamydia to prevent pelvic inflammatory disease in women","volume":"35","author":"Gift","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib55","doi-asserted-by":"crossref","first-page":"e11413","DOI":"10.1371\/journal.pone.0011413","article-title":"Cost-effectiveness of an intervention to reduce HIV\/STI incidence and promote condom use among female sex workers in the Mexico-US border region","volume":"5","author":"Burgos","year":"2010","journal-title":"Plos One"},{"key":"10.1016\/j.jval.2013.10.005_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/sti.2006.024364","article-title":"The cost effectiveness of opportunistic chlamydia screening in England","volume":"83","author":"Adams","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.olq.0000154501.22566.fa","article-title":"The cost effectiveness of gonorrhea screening in urban emergency departments","volume":"32","author":"Aledort","year":"2005","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib58","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1524-4733.2007.00225.x","article-title":"De Jong-van den Berg L, Postma M. Cost-utility of repeated screening for Chlamydia trachomatis","volume":"11","author":"De Vries","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2013.10.005_bib59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/sextrans-2011-050067","article-title":"The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland","volume":"88","author":"Gillespie","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-141-7-200410050-00006","article-title":"Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis","volume":"141","author":"Hu","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2013.10.005_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.olq.0000200577.46261.b0","article-title":"The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies","volume":"33","author":"Hu","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1071\/SH06016","article-title":"The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia","volume":"3","author":"Walleser","year":"2006","journal-title":"Sex Health"},{"key":"10.1016\/j.jval.2013.10.005_bib63","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/01.olq.0000225321.61049.13","article-title":"Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies","volume":"34","author":"Smith","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.olq.0000225321.61049.13","article-title":"Hospitalization for pelvic inflammatory disease: a cost-effectiveness analysis","volume":"34","author":"Smith","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14070","article-title":"The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation","volume":"14","author":"Shepherd","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2013.10.005_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1403494809357260","article-title":"A cost-effectiveness analysis of the Chlamydia Monday\u2014a community-based intervention to decrease the prevalence of chlamydia in Sweden","volume":"38","author":"Deogan","year":"2010","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jval.2013.10.005_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/OLQ.0b013e31824717ae","article-title":"Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada","volume":"39","author":"Tuite","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007435-200305000-00001","article-title":"A refined estimate of the average lifetime cost of pelvic inflammatory disease","volume":"30","author":"Yeh","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib69","doi-asserted-by":"crossref","first-page":"A62","DOI":"10.1136\/sextrans-2011-050109.88","article-title":"The cost of expedited partner therapy compared to the cost of standard partner referral for the treatment of chlamydia or gonorrhoea","volume":"87","author":"Gift","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2004.03.008","article-title":"Costs and net health effects of contraceptive methods","volume":"69","author":"Sonnenberg","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jval.2013.10.005_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/OLQ.0b013e31815b07dd","article-title":"Quality of life utilities for pelvic inflammatory disease health states","volume":"35","author":"Smith","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jval.2013.10.005_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/sextrans-2011-050187","article-title":"Adolescent and parental utilities for the health states associated with pelvic inflammatory disease","volume":"87","author":"Trent","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib73","series-title":"Vaccines for the 21st Century: A Tool for Decisionmaking","year":"1999"},{"key":"10.1016\/j.jval.2013.10.005_bib74","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.AOG.0000279153.56275.b5","article-title":"Effect of noncancerous pelvic problems on health-related quality of life and sexual functioning","volume":"110","author":"Kuppermann","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jval.2013.10.005_bib75","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.fertnstert.2003.09.064","article-title":"Preferences for fertility in women with pelvic inflammatory disease","volume":"81","author":"Songer","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jval.2013.10.005_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/11597720-000000000-00000","article-title":"Health utility elicitation: is there still a role for direct methods?","volume":"30","author":"Prosser","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2013.10.005_bib77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3816\/CLC.2008.n.026","article-title":"Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer","volume":"9","author":"LoConte","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jval.2013.10.005_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-11-56","article-title":"HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection","volume":"11","author":"Herrmann","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2013.10.005_bib79","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1023\/B:QURE.0000040794.77438.cf","article-title":"Urinary incontinence in women under 65: quality of life, stress related to incontinence and patterns of seeking health care","volume":"13","author":"Margalith","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2013.10.005_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/sti.2006.023333","article-title":"The association between knowledge of HPV and feelings of stigma, shame and anxiety","volume":"83","author":"Waller","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jval.2013.10.005_bib81","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yebeh.2012.02.025","article-title":"The development of a QALY measure for epilepsy: NEWQOL-6D","volume":"24","author":"Mulhern","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jval.2013.10.005_bib82","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0895-4356(99)00074-8","article-title":"Are health states timeless? The case of the standard gamble method","volume":"52","author":"Bala","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2013.10.005_bib83","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0272989X05276854","article-title":"The QALY model and individual preferences for health states and health profiles over time: a systematic review of the literature","volume":"25","author":"Tsuchiya","year":"2005","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2013.10.005_bib84","unstructured":"Pharmaceutical Benefits Advisory Committee. Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). Canberra, Australia: Australian Government Department of Health and Ageing, 2008. Available from: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/pbacguidelines-index. [Accessed May 10, 2013]."},{"key":"10.1016\/j.jval.2013.10.005_bib85","unstructured":"Althaus C., Turner K.M.C., Mercer C., et al. Clinical and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections. Health Technol Assess. In press."},{"issue":"Suppl","key":"10.1016\/j.jval.2013.10.005_bib86","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1097\/01.olq.0000235149.41948.fa","article-title":"The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims","volume":"33","author":"Gift","year":"2006","journal-title":"Sex Transm Dis"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301513043593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301513043593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:59:40Z","timestamp":1565103580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301513043593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1098301513043593"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2013.10.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}